Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Grifols, a holding company specialized in the pharmaceutical-hospital sector and in the production of plasma derivatives, has acquired the industrial complex adjacent to the facilities of its Biomat Company, in Parets del Valles.
Subscribe to our email newsletter
The acquired industrial complex covers a surface area of 31,000 square meters, of which 6,000 m2 is a parcel of land on which the company plans to build a new plasma fractionation plant which will allow it to double its current capacity in Spain. This acquisition was brokered by the real estate firm Jorda & Guasch.
Grifols is in the final stage of finishing another two buildings in the same industrial area which will be in use by the second quarter of 2008. The first of these is more than 3,500 meters squared on two levels, and will be the future home of general management, the technical area, administration and part of the hospital division’s storage area for raw materials.
The second building is 6,000 square meters and has two floors. Grifols Engineering will have new facilities on the first floor to carry out its engineering and also some general services. On the second floor, various corporate offices from different areas will be relocated to optimize resources and improve the company’s overall efficiency.
Twose, vice president of production at Grifols, said: “This acquisition forms part of the investment plan which amounts to a total of 400 million euros. This plan was recently approved with the objective of increasing our production capacity for plasma derivatives and guaranteeing the company’s growth.”